These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9310834)

  • 21. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H; Kokla A; Trakas N; Tzartos SJ
    Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjugation of acetylcholine receptor-protecting Fab fragments with polyethylene glycol results in a prolonged half-life in the circulation and reduced immunogenicity.
    Trakas N; Tzartos SJ
    J Neuroimmunol; 2001 Nov; 120(1-2):42-9. PubMed ID: 11694318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiacetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF; de Baets MH; Burton DR
    Ann N Y Acad Sci; 1998 May; 841():414-7. PubMed ID: 9668268
    [No Abstract]   [Full Text] [Related]  

  • 24. VH gene family utilization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus YM; Verschuuren JJ; Bos NA; van Breda Vriesman PJ; De Baets MH
    J Neuroimmunol; 1993 Mar; 43(1-2):113-24. PubMed ID: 8458983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
    Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and characterization of a single-chain antibody fragment derived from thymus of a patient with myasthenia gravis.
    Meng F; Stassen MH; Schillberg S; Fischer R; De Baets MH
    Autoimmunity; 2002 Mar; 35(2):125-33. PubMed ID: 12071435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis.
    Cardona A; Garchon HJ; Vernet-der-Garabedian B; Morel E; Gajdos P; Bach JF
    J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis.
    Vincent A; Willcox N; Hill M; Curnow J; MacLennan C; Beeson D
    Immunol Rev; 1998 Aug; 164():157-68. PubMed ID: 9795773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes.
    Link H; Xu ZY; Melms A; Kalbacher H; Sun JB; Wang ZY; Fredrikson S; Olsson T
    Scand J Immunol; 1992 Sep; 36(3):405-14. PubMed ID: 1381518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimmunology of myasthenia gravis.
    Vincent A
    Brain Behav Immun; 1988 Dec; 2(4):346-51. PubMed ID: 3076486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor.
    Protti MP; Manfredi AA; Wu XD; Moiola L; Dalton MW; Howard JF; Conti-Tronconi BM
    J Clin Invest; 1992 Oct; 90(4):1558-67. PubMed ID: 1383275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.
    Saxena A; Stevens J; Cetin H; Koneczny I; Webster R; Lazaridis K; Tzartos S; Vrolix K; Nogales-Gadea G; Machiels B; Molenaar PC; Damoiseaux J; De Baets MH; Simon-Keller K; Marx A; Vincent A; Losen M; Martinez-Martinez P
    Sci Rep; 2017 Oct; 7(1):14426. PubMed ID: 29089519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for an antigen-driven selection process in human autoantibodies against acetylcholine receptor.
    Cardona A; Pritsch O; Dumas G; Bach JF; Dighiero G
    Mol Immunol; 1995 Nov; 32(16):1215-23. PubMed ID: 8559146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor.
    Papanastasiou D; Mamalaki A; Eliopoulos E; Poulas K; Liolitsas C; Tzartos SJ
    J Neuroimmunol; 1999 Feb; 94(1-2):182-95. PubMed ID: 10376952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: autoantibody mediated up-regulation of the response of acetylcholine receptor-specific T lymphocytes.
    Zhang Y; Tzartos S
    Immunology; 1992 Dec; 77(4):571-6. PubMed ID: 1283599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.